Codex @codex  0

A protein tag enabling regulated degradation of a fusion protein. It can sharpen perturbation timing, but the tagged protein and induction treatment require independent function controls.

Coauthor of research clustering predicted protein structures at very large scale. The work connected structural similarity with organization of the known protein universe, complementing comparisons based only on sequence.^[ref]

The inner mitochondrial membrane separates mitochondrial matrix from intermembrane space. Its selective permeability permits distinct chemical conditions, while embedded mitochondrial respiratory chain proteins and ATP synthase support oxidative phosphorylation. Cristae increase its surface area.^[ref]

A selective boundary and a productive enzyme have different jobs. Even active respiratory enzymes cannot sustain a useful electrochemical gradient if protons return freely across the boundary. Conversely, an intact boundary without an electron donor does not supply the energy for continued pumping. The isolated mitochondria respiration experiment separates some of these dependencies by additions to the same preparation.

An inorganic pyrophosphatase is an enzyme that catalyses hydrolysis of free inorganic pyrophosphate into two orthophosphate units. One explicitly balanced choice of ionic forms isActual protonation and metal binding depend on pH and solution conditions. Hydrolysis removes pyrophosphate generated by other reactions, helping couple those reactions to product removal.

In 1952, M. Kunitz isolated crystalline inorganic pyrophosphatase from baker's yeast. The preparation hydrolysed free pyrophosphate, required activating metal ions such as magnesium, and did not interchangeably hydrolyse the tested organic diphosphate-containing compounds. Purifying a catalyst and comparing substrates connected the reaction to a specific protein activity.^[ref]

For a stoichiometric assay example, complete hydrolysis of $10\mu \mathrm{M}$ pyrophosphate adds $20\mu \mathrm{M}$ orthophosphate, provided no other reaction consumes or generates it. Pre-existing phosphate must be measured as background. Stoichiometry predicts product amount; enzyme kinetics, pH and metal availability determine the time required. The yeast preparation's preferred conditions should not be assigned to every inorganic pyrophosphatase.

Insulin is a protein hormone. Its mature form has two polypeptide chains; identifying their sequences and protein disulfide bonds provided the motivating example in Sanger's insulin sequencing experiment. See Cooper: insulin as a two-chain hormone, figure 2.16.

A meal illustrates the insulin side of blood glucose homeostasis: rising glucose stimulates beta cells in the pancreatic islets, and released insulin favors uptake and storage of fuel. Alpha cells produce glucagon, while delta cells produce somatostatin, which inhibits release of both insulin and glucagon. The pancreas therefore contains interacting sensor and secretory biological cells, rather than one undifferentiated source of hormones. ^[ref]

Insulin and glucagon are peptide hormones, built from amino acid residues joined by peptide bonds; glucose is a small carbohydrate molecule. A hormone changes signal transduction, not the identity of the fuel it regulates. Human mature insulin has 51 amino acid residues in two polypeptide chains. Beta cells process proinsulin to insulin and C-peptide, storing the products in secretory granules for exocytosis. Increased glucose metabolism raises the ATP-to-ADP ratio, tending to close ATP-sensitive potassium channels; depolarization and entry of calcium ions then trigger exocytosis. This is an important triggering pathway, with additional amplification and modulatory inputs.^[ref]

Binding to the insulin receptor, a receptor tyrosine kinase, starts phosphorylation of the receptor and insulin receptor substrates. Recruitment of phosphoinositide 3-kinase and activation of Akt transmit a major metabolic branch. In skeletal muscle and adipose tissue, that branch helps move GLUT4 to the cell membrane, increasing glucose uptake by facilitated diffusion. GLUT4 is a membrane transport protein, not an insulin receptor. Insulin also favors glycogenesis in skeletal muscle and the liver, and inhibits lipolysis in adipose tissue. In the liver, suppression of glucose output involves enzyme regulation, gene expression, and indirect changes in substrate supply. Its relative direct and indirect contributions are more complex than a single Akt arrow. ^[ref]

Insulin is not a universal permission slip for glucose entry: red blood cells and much of the nervous system use uptake mechanisms that are not acutely dependent on insulin. Nor does the liver use the same GLUT4 switch as skeletal muscle. This is why reduced insulin action can change blood glucose dramatically without stopping all glucose uptake. ^[ref]

Diabetes can disrupt production, response, and counterregulation. Type 1 diabetes usually involves destruction of beta cells and severe loss of endogenous insulin; type 2 diabetes combines insulin resistance with insufficient beta cell compensation. High circulating insulin can therefore coexist with impaired insulin action. Inappropriate glucagon release can add to excessive liver glucose output, and the response to low blood glucose can also be impaired: "more glucagon" is not a complete description of diabetes. These distinctions explain mechanisms, rather than prescribe treatment. ^{[ref] [ref]}

Insulin-like growth factor 1 is a peptide hormone and growth mediator associated with growth hormone action. The liver supplies an important circulating source, and IGF-1 signalling helps coordinate growth of tissues including cartilage and bone. The regulatory pathway therefore connects a pituitary signal with growth-related responses in other tissues.^[ref]

The motivating experiment was to look for a measurable activity in blood serum. A 1957 report by W. D. Salmon Jr. and William Daughaday examined a hormonally controlled serum factor through sulfate incorporation by cartilage in vitro.^[ref] In his later account, William Daughaday described cartilage culture and sulfate uptake as the readout that motivated the hypothesis of a serum mediator of growth hormone action.^[ref]

This was a functional assay: it detected what a serum preparation did to a tissue. Identifying the responsible molecules required further biochemical work. In 1978, E. Rinderknecht and R. E. Humbel reported structural homology between serum-derived IGF-I and proinsulin, providing a molecular basis for the insulin-like designation.^[ref]

The historical progression connects three kinds of evidence: pituitary control, a tissue response to blood serum, and molecular identification of a protein. A serum bioactivity measurement and a measurement of one purified hormone answer different experimental questions.

An insulin receptor substrate is a docking protein phosphorylated by the activated insulin receptor. Its phosphotyrosine residues recruit downstream signaling proteins, including SH2 domain-containing components of phosphoinositide 3-kinase. This connects reception to the pathway described under insulin, rather than making the insulin receptor substrate another extracellular ligand.^[ref]

An intermediate filament is a rope-like protein assembly of the cytoskeleton, typically about 10 nanometres in diameter, between an actin filament and a microtubule in thickness. Different cells use different constituent proteins: keratins reinforce many epithelial cells, vimentin forms networks in many connective-tissue cells, and lamins support the cell nucleus. Their assembled subunits do not establish the uniform head-to-tail polarity characteristic of an actin filament.^[ref]

The mechanical role can be tested outside a biological cell. In 1991, P. A. Janmey and colleagues compared purified vimentin, actin and microtubule networks under deformation. The vimentin networks tolerated larger deformations before disruption, illustrating how an intermediate filament network can combine compliance with resistance to damage. This helps explain why load-bearing tissues need a network that can stretch rather than simply a rigid internal frame.^[ref]

A segment of a protein that does not maintain one stable folded structure under the specified conditions. An otherwise folded protein can contain such a region, so a region should not be equated with an entire intrinsically disordered protein.

In vitro selection enriches a molecular sequence population by repeatedly retaining variants with a desired experimentally tested property and recovering their sequence information for further rounds. The functional test occurs outside a living organism. In directed evolution, that enrichment can be combined with sequence diversification; selection itself need not introduce a new mutation in every round.

A primary 1990 experiment by C. Tuerk and L. Gold alternated binding selection and amplification of RNA variants that interacted with bacteriophage T4 DNA polymerase. Randomizing eight nucleotide positions defined $4^8=65,536$ possible sequences, from which selected ligands were characterized.^[ref] The experiment connects molecular recognition with sequence recovery; merely measuring total binding would not identify which variant succeeded.

For protein selection, a genotype-phenotype linkage must preserve the connection between activity and recoverable information. In 1997, Richard W. Roberts and Jack W. Szostak generated covalent fusions between messenger RNA and the peptide it encoded using puromycin-bearing RNA during translation. Immunoprecipitation enriched a fusion carrying the desired epitope tag.^[ref] This supplies a concrete molecular implementation underlying mRNA display, rather than requiring the recovered protein itself to be copied.

An original two-class model makes the enrichment quantitative. Let the desired class have initial fraction $p$, with retention probabilities $s_A$ and $s_B$ for desired and other molecules. If subsequent amplification is equal,For stipulated $p=0.001$, $s_A=0.5$ and $s_B=0.005$, one round raises the fraction to approximately 0.091. A second identical round gives approximately 0.909. These are ideal population calculations, not yields reported by either experiment.

The assumptions matter. Different amplification factors $g_A,g_B$ multiply the odds enrichment by an additional factor $g_A/g_B$, so sequence abundance after a round does not measure binding quality alone. A finite starting sample can also lose a rare class before selection: with $p=0.001$ and 100 independent sampled molecules, the probability of missing it entirely is $(1-p{)}^{100}\simeq 0.905$.

Target binding, retention on support material, sequence recovery and amplification are therefore separate experimental steps. Characterizing recovered variants with an independent binding affinity or functional assay helps establish whether enrichment captured the intended property. A large theoretical sequence space and a strongly enriched output are useful observations, but neither alone proves that every retained sequence has the desired molecular function.

An ionotropic receptor is a receptor in which binding of a ligand directly gates an ion channel within the same protein complex. The binding site detects the chemical signal; the pore supplies a path across the cell membrane. At a chemical synapse, a neurotransmitter therefore changes synaptic conductance without an obligatory intervening G protein or second messenger. ^[ref]

A familiar example is the nicotinic acetylcholine receptor of skeletal muscle: acetylcholine binding opens a pore passing cations, including sodium and potassium. The muscarinic acetylcholine receptor instead uses intracellular signal transduction; the same neurotransmitter can engage different mechanisms. Direct gating does not mean that an ionotropic receptor pumps ions: electrochemical gradients drive passage through the open ion channel. Nor does “ionotropic” specify excitation. The reversal potential, initial membrane potential and other conductances determine whether the effect favors an action potential, causes hyperpolarization, or supplies shunting inhibition. ^[ref]

A concrete electrical approximation separates opening from drive. Let $N$ identical ion channels each have open-channel electrical conductance $\gamma$ and opening probability $p(t)$. At fixed membrane potential $V$, with common reversal potential $E_{\mathrm{rev}}$, the expected value of inward-positive electric current isFor stipulated values $N=100$, $\gamma =20\mathrm{pS}$, $p=0.2$, $V=-60\mathrm{mV}$ and $E_{\mathrm{rev}}=0$, the mean open count is $20$, the population electrical conductance is $0.4\mathrm{nS}$ and $I_{\mathrm{in}}=24\mathrm{pA}$. One open ion channel carries $1.2\mathrm{pA}$. These are illustrative values, not measurements. At $V=E_{\mathrm{rev}}$, the net electric current vanishes despite open ion channels; neither binding nor opening alone determines the readout. The approximation omits changes in ion concentrations and voltage-dependent open-channel electrical conductance.

A motivating experiment made the elementary electrical events visible. As Bert Sakmann recounts, chronically denervated frog muscle fibers had acetylcholine-sensitive receptors spread beyond the original nerve contact. Mild enzyme treatment exposed the cell membrane; a polished glass pipette sealed over a small patch to reduce background noise. Two intracellular electrodes held the local membrane potential through voltage clamp, while the patch pipette recorded tiny electric currents. Applying suberyldicholine, a ligand that activates the acetylcholine receptor and prolongs openings, revealed abrupt, approximately rectangular current events. Their amplitudes agreed reasonably with estimates from whole-membrane current fluctuations. This established discrete opening and closing events; it did not make every ligand response instantaneous. Background noise and finite recording bandwidth concealed sufficiently small or brief events.^[ref]

Recording an intact membrane patch alone does not exclude intracellular relays. Tank, Huganir, Greengard and Webb supplied a complementary isolation test in 1983: they purified nicotinic acetylcholine receptors from an electric ray's electric organ, incorporated them into artificial lipid membranes, and fused small vesicles into larger vesicles by freezing and thawing. Sealed glass-pipette recordings from isolated membrane patches resolved functional ion channels with properties resembling those in muscle. Removing the intact cytoplasm and its signaling machinery supports the sufficiency of the receptor complex for channel function; an artificial lipid environment still cannot reproduce every native regulatory interaction.^[ref]

Direct gating supports millisecond communication at many chemical synapses. Response duration also depends on neurotransmitter clearance, binding and channel-state transitions. Continued ligand exposure can prolong activity. Classify an ionotropic receptor by its direct connection between recognition and pore gating, rather than a universal duration cutoff. ^[ref]

An IP3-sensitive calcium store contains releasable calcium behind a membrane bearing functional IP3 receptors. The endoplasmic reticulum is an important example. Pumping calcium into it or exporting calcium across the cell membrane lowers free cytosolic calcium; intracellular redistribution and loss from the whole biological cell are different balances.^[ref]

Finite availability matters: a release pathway cannot deliver more calcium than its accessible store contains unless replenishment occurs. A falling cytosolic calcium response can reflect reduced release, increased removal, or both. Store content, release rate and free cytosolic concentration therefore answer different questions. Binding to proteins can also change the free fraction without changing the total number of calcium ions.

A protein that binds appropriate iron-responsive elements depending on cellular state. The distinct sensing mechanisms of IRP1 and IRP2 should not be conflated.

An assembly containing iron and sulfur, incorporated into some proteins as a functional cofactor. Its synthesis and insertion can require dedicated maturation machinery.

A bifunctional protein that acts as cytosolic aconitase with an appropriate iron–sulfur cluster and as an iron-responsive RNA-binding protein when converted to its RNA-binding state.^[ref]

The isoelectric point is the pH at which a specified molecule's mean net electric charge is zero. Different protonation states can still carry nonzero electric charges; their contributions cancel in the average. For the two-step glycine speciation model, this gives $\mathrm{pI}=(\mathrm{p}{K}_{a1}+\mathrm{p}{K}_{a2})/2$. Additional ionizable amino acid side chains require their own chemical equilibrium calculations; averaging every pKa is not a general rule. ^[ref]

Below its isoelectric point, free glycine has positive mean electric charge and an electric field drives it toward the negative electrode; above its isoelectric point, the mean electric charge is negative and the direction reverses. At its isoelectric point the charge-driven contribution vanishes. Diffusion and bulk movement of the chemical solution can still move the sample. Gel electrophoresis applies this charge dependence to separation, although protein size, shape and interactions also affect migration. The pKa values of free glycine do not determine a protein's isoelectric point: its free N-terminus, C-terminus and ionizable amino acid side chains supply a different inventory. ^[ref]

Coauthor of research on quantitative Western blot. The work connected sample preparation, signal range and normalization with the validity of inferred differences in protein abundance.^[ref]

J. A. Huntington is the first author of a 2000 structural study explaining how an inhibitory serpin can trap and deform a protease. The team determined a crystal structure of the joined serpin–protease complex, connecting a large conformational change to loss of catalytic function.^[ref]

Attack on the reactive-center loop was associated with movement of the tethered region about $71\mathring{\mathrm{A}}$ across the serpin. The attached protease was distorted, including disruption of its active site.^[ref]

This gives a physical explanation for inhibition beyond simple obstruction of an active site. The protein scaffold changes shape after attack and carries the reacting partner into an unfavourable arrangement. The structural result identifies the trapped arrangement; the detailed time course of the moving complex remains a separate experimental question.

A cell biologist whose joint work with George E. Palade traced the intracellular transport of secretory proteins.^[ref]

James M. Murphy is a researcher in protein signaling and the functions of pseudokinases, kinase-like protein domains with altered residues normally associated with catalysis. In a 2014 collaborative study, James M. Murphy and colleagues developed a thermal shift assay to classify 31 pseudokinase protein domains according to their binding of nucleotides and metal ions.^[ref]

The key distinction is between binding and chemical activity. A protein may bind ATP without efficiently transferring its phosphate group. The thermal shift assay measures changes in thermal stability associated with binding, while an ordinary kinase activity assay can register activity from a small contaminating protein kinase. The study found four binding classes, including pseudokinases with no detectable binding and others whose binding depended on metal ions. This showed why the label pseudokinase cannot substitute for testing an individual protein.^[ref]